MarketWatch
Analyze & Strategize
Top News
Techies may escape the axe in tech layoff season – Moneycontrol
Whenever there is a downturn, the very first cost reduction happens with teams that are responsible for growth, engineering, product and design functions are the last functions to get impacted, said an expert. Read More
reported by Deepsekhar Choudhury at Moneycontrol
Strong Demand Drives Economy Past Inflation For Now, Indicators Show – NDTV Profit
India’s economy maintained its momentum in April as a wider reopening from the pandemic kept rising prices from depressing demand for the time being. Read More
reported by at NDTV News
Market LIVE Updates: Nifty around 16,250; Bajaj twins top gainers, RIL, HDFC Bank, TCS most active – Moneycontrol
Stock Market LIVE Updates: Except oil & gas and metals, all other sectoral indices are trading in the green with the midcap and smallcap indices up 1 percent each. Read More
reported by Rakesh Patil at Moneycontrol
Falling markets: How much longer, and how to invest until they recover? – The Indian Express
Since the RBI announced its rate hike on May 4, the Sensex has fallen 4.8%. By comparison, the mid-cap and the small-cap indices are down 8.9% and 10.7% respectively. Read More
reported by Sandeep Singh at The Indian Express
Meet the most robust App for smartest Traders
Analyze.
Strategize.
Stay Ahead,
Always.
Downloads
From the blogs
Has Moody’s rated India fairly visvis peers? – Moneycontrol.com
Even if calendar year growth of 8.8 percent and 8.3 percent are considered, India would still be the fastest-growing economy. India?s adequacy of foreign exchange reserves should be the least of the worries for credit rating agencies. Read More reported by at...
This is Why Bharat Biotech’s Covaxin Failed to be the Hero of India’s Vaccination Story Against Covid News18
Complex processes, scattered production units, need for more safety zones and shortage of skilled staffers are some of the top reasons that restricted Bharat Biotech?s Covaxin from becoming the poster-boy of India?s vaccination story against Covid-19. Read More...
Biocon Biologics gets license to manufacture antibody treatment for Covid Hindustan Times
US-based Adagio Therapeutics has allowed the company to manufacture and commericalise the ADG20-based treatment in India, as well as in select markets. | Latest News India Read More reported by hindustantimes.com at Hindustan...